Vistra, the Singapore-based provider of advisory and administrative services with USD370bn AuA, has been appointed as administrator for the AMR Action Fund. Vistra will support the fund across its entire structure, including the management company, the fund, its SPVs, and portfolio company investments. The AMR Action Fund is the world’s largest public-private partnership supporting the development of new antibiotics. It aims to accelerate the development of new antibiotics by investing more than USD1bn in smaller biotech companies and providing industry expertise.
